BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:The innate immune system is increasingly being recognised as a target for a range of exciting applications with high unmet need\, from those difficult to treat cancers to infectious and inflammatory disease.\ n\nThe past year has seen a mix of ups and downs for this space\, with se veral companies entering the clinic\, emerging new modalities of STING/TL R agonists and on the other side some clinical setbacks.\n\nThe 5th Annua l STING and TLR Targeted Therapies Summit returns at a crucial time to un pick the lessons of the past year and finally unleash the well-recognised potential of innate immunotherapy.\n\nIn this dynamic field which contin uously sees new approaches\, keep track of all the goings on within indus try\, learn the best approach for selecting the right patient population and how to strike that ever tricky balance of safety and efficacy.\n\nThi s meeting covers everything from early discovery to clinical trial ration ale across the innate immune pathway including TLR\, STING and broader in nate immune system targets like PTPN2/PTPN1 and RNA modifying enzymes\, a longside evaluating the rationale for combination approaches with checkpo int inhibitors and beyond.\n\nThis meeting will once again converge the k ey players in STING/TLR and beyond\, with actionable insights to unlock t he potential of harnessing the innate immune system to meet unmet needs.\ n\nURLs:Tickets: \;https://go.evvnt.com/2277808-2?pid=185Brochure:&nb sp\;https://go.evvnt.com/2277808-3?pid=185\n\nPrices:Conference + 2 Works hops - Drug Developer: USD 4197.00\,Conference + 1 Workshop - Drug Develo per: USD 3598.00\,Conference Only - Drug Developer: USD 2999.00\,Conferen ce + 2 Workshops - Solution Provider: USD 5097.00\,Conference + 1 Worksho p - Solution Provider: USD 4398.00\,Conference Only - Solution Provider: USD 3699.00\,Conference + 2 Workshops - Academic: USD 3597.00\,Conference + 1 Workshop - Academic: USD 3098.00\,Conference Only - Academic: USD 25 99.00\n\nSpeakers: \;Aarron Willingham\, Executive Director\, Merck a nd Co\, Anna Galkin\, CSO\, Axelia Oncology\, Dae-Shik Kim Sr.\, Principa l Scientist\, Eisai\, Dimple Modi\, Director - Precision Medicine\, Regen eron\, Dinesh Chandra\, Associate Director\, Interventional Oncology\, Jo hnson and Johnson\, Diwakar Davar\, Associate Professor and Director - Me lanoma Clinical and Skin Cancer Program\, University of Pittsburgh Medica l Center\, Elena Bekerman\, Senior Scientist - Research and Virology\, Gi lead Sciences\, James Appleman\, Co- Founder\, Chief Scientific Officer\, Senior Vice- President and Director - Research and Development\, Primmun e Therapeutics\, Inc.\, Kathleen McGuire\, Principal Research Scientist\, Abbvie\, Kevin Heller\, Chief Medical Officer\, Tallac Therapeutics\, Le i Jin\, Associate Professor (tenured)\, University of Florida\, Maddie Ol son\, Clinical Scientist\, OncoNano Medicine Inc.\, Michael Newman\, Foun der and Chief Scientific Officer\, Indaptus Therapeutics\, Paul Song\, Ch ief Scientific Officer\, Genequantum Healthcare\, Roy Baynes\, Executive Vice President and Chief Medical Officer\, Eikon Therapeutics\, Scott Pes iridis\, Scientific Director and GSK Fellow\, GlaxoSmithKline Plc\, Steve n Katz\, Chief Medical Officer\, TriSalus Life Sciences\, Tony Zhang\, Co -founder and CEO\, Tyligand\, Yaara Ofir-Rosenfeld Director\, Translation al Oncology\, STORM Therapeutics Ltd.\, Zer En Peng\, Research Analyst\, Beacon\n\nDate and Time: \;19th June 2024 at 8:00 am to 20th June 202 4 at 4:30 pm\n DTEND:20240620T163000 DTSTAMP:20260512T232254Z DTSTART:20240619T080000 LOCATION:Sheraton Mission Valley San Diego Hotel\, 1433\, Camino del Rio S outh\, San Diego\, California\, 92108\, SEQUENCE:0 SUMMARY:The innate immune system is increasingly being recognised as a tar get for a range of exciting applications with high unmet need\, from thos e difficu... UID:6faef4b9-05ae-4ff3-8b7a-d888d1f9639d END:VEVENT END:VCALENDAR